Tohru Ohmori

Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2

Tohru Ohmori, Eckhard R. Podack, Kauto Nishio et al. · Biochemical and Biophysical Research Communications · 1993 · 167 citations

Medicine, Oncology, Pharmacology +14

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line

Naohiro Kubota, Fumihiko Kanzawa, Kazuto Nishio et al. · Biochemical and Biophysical Research Communications · 1992 · 98 citations

Medicine, Molecular Biology, Oncology +9

Antitumor activity of the selective epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) Iressa® (ZD1839) in an EGFR‐expressing multidrug‐resistant cell line <i>in vitro</i> and <i>in vivo</i>

Ichiro Naruse, Tohru Ohmori, Yoko Ao et al. · International Journal of Cancer · 2001 · 89 citations · Full text

Medicine, Oncology, Pharmacology +15

Blockade of Tumor Cell Transforming Growth Factor-βs Enhances Cell Cycle Progression and Sensitizes Human Breast Carcinoma Cells to Cytotoxic Chemotherapy

Tohru Ohmori, Jin-Long Yang, James O. Price et al. · Experimental Cell Research · 1998 · 83 citations

Medicine, Cell Biology, Oncology +14

Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell Line

Sei Ohta, Kazuto Nishio, Naohiro Kubota et al. · Japanese Journal of Cancer Research · 1994 · 66 citations · Full text

Medicine, Oncology, Pharmacology +13